1 / 7

Biodefense Market Size, Cost Structures, Growth rate and Industry Analysis to 2027

An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.

samvi
Download Presentation

Biodefense Market Size, Cost Structures, Growth rate and Industry Analysis to 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biodefense Market To Reach USD 7.64 Billion By 2026

  2. Market Summary Supportive government initiatives in medical countermeasure preparedness against biological threats is a significant factor estimated to stimulate market demand. Market Size – USD 5.39 billion in 2018, Market Growth - CAGR of 4.4%, Market Trends – Increasing incidences of infectious diseases

  3. Our Approach Our Approach Market Summary The global biodefense market is expected to reach USD 7.64 Billion by 2026, according to a new report by Reports and Data. Biodefense involves the use of medical procedures to safeguard individuals against bioterrorism. Biodefense comprises interventions like drugs and vaccinations along with research and public health preparations to countermeasure bioterrorism. Supportive government initiatives in medical countermeasure preparedness against biological threats is a significant factor estimated to stimulate market demand during the forecast period. Governments across the globe, especially in developed countries, make massive funding every year for the R&D of vaccines to thwart any biological threat. The Biomedical Advanced Research and Development Authority (BARDA), a part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response, was established in 2006 to help keep the nation safe from chemical, biological, radiological, and nuclear (CBRN) threats, along with a focus on pandemic influenza (PI) and emerging infectious diseases (EID). The initiatives of governments worldwide open a window of opportunities for the firms involved in the biodefense sector. Requestfor a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/1410

  4. Our Approach Our Approach Market Summary Further key findings from the report suggest • Anthrax vaccines contributed to the largest market share in 2018 and is expected to have a CAGR of 4.1% while maintaining its dominance throughout forecast period. Its growth is attributed to increase spending by the governments across the globe to develop and store sufficient vaccines against anthrax. • The civilian segment is anticipated to account for a significant share of the market over the forecast period. • North America held the largest market share of over 70% in 2018 and is expected to witness a growth rate of 4.2% in the forecast period. The U.S. government implements a number of initiatives that assist them in reinforcing security against biological threats. • Moreover, several programs focused on preparedness and prevention of intentional or accidental releases of biological agents will fuel the market growth in the forecast period. To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/biodefense-market

  5. Our Approach Our Approach Market Summary Key participants include Altimmune, Emergent BioSolutions, SIGA Technologies, Elusys Therapeutics, Ichor Medical Systems, DynPort Vaccine Company, Cleveland BioLabs, Bavarian Nordic, Achaogen, and Alnylam Pharmaceuticals among others. For the purpose of this report, Reports and Data have segmented global biodefense market on the basis of product type, application, sales channel, and region: Product Type Outlook (Revenue, USD Million; 2016-2026) Anthrax Vaccine Small Pox Vaccine Botulism Vaccine Radiation Vaccine Others

  6. Our Approach Our Approach Market Summary Application Outlook (Revenue, USD Million; 2016-2026) Military Civilian Sales Channel Outlook (Revenue, USD Million; 2016-2026) Direct Sales Distribution Order Now: https://www.reportsanddata.com/checkout-form/1410

  7. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related